Clinical Trial Update: Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients [Phase 1]

View source ↗

Summary

The document reports the Phase 1 safety and efficacy study of the antiviral candidate NVR 3-778 in healthy volunteers and patients with chronic hepatitis B. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• NVR 3-778

Snippet

Sponsor: Novira Therapeutics, Inc. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED